Osteotech boosted by DePuy settlement on Dynagraft
This article was originally published in Clinica
Osteotech, which has been suing GenSci Regeneration Sciences over alleged infringements of bone cement patents since early 1998, has reached a settlement with GenSci's distributor, Johnson & Johnson's DePuy subsidiary. DePuy has agreed to stop selling GenSci's Dynagraft gel and putty. In addition DePuy will pay up to $3 million to Osteotech.